Market Size of Tendonitis Treatment Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 3.57 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Tendonitis Treatment Market Analysis
The tendonitis treatment market is expected to register a CAGR of 3.57% during the forecast period.
The COVID-19 pandemic is an unprecedented health concern and significantly impacted the tendonitis treatment market worldwide. The shortage of healthcare professionals for treating tendonitis hampered the development and growth of the market during the COVID-19 pandemic. Besides, the cancellation of sports activities resulted in fewer sports injuries, thereby negatively impacting the tendonitis treatment market. In addition, according to a 2021 update by the National Safety Council (NSC) of America, the Consumer Product Safety Commission (CPSC) reported that during the first seven months of the COVID-19 pandemic, visits to emergency departments for consumer product-related injuries fell by 24%. The largest decrease occurred in April, with a 45% decrease. Over the full year, consumer product injuries treated in emergency departments decreased by 18% in 2020 compared to 2019. The highest decrease in injuries was sports-related injuries associated with track and field. However, since the lockdown restrictions were lifted, the industry has been recovering well. Following the record low number of consumer product-related injuries reported in 2020, injuries increased by 6.8% in 2021.
The factors that are fueling the market include the rising burden of sports injuries and the consistent innovation of new products and treatment modalities. The National Safety Council (NSC) reports that in 2021, injuries caused by exercise equipment accounted for nearly 409,000 of all sports and recreation-related injuries. In addition, bicycles and accessories accounted for 375,797 injuries in the year 2021 in the United States. Thus, a significant number of sports-related injuries may increase tendonitis leading to rising demand for its treatment, thereby fueling the growth of the studied market.
Moreover, the increasing efforts undertaken by major market players to develop technologically advanced products may contribute to the tendonitis treatment market's growth. For instance, in September 2021, Ossur, a global innovator in prosthetic and non-invasive orthopedic technologies, launched the new Rebound Post-Op Elbow Brace, a non-invasive, lightweight, adjustable brace designed to provide elbow immobilization and range-of-motion restrictions for patients with a variety of conditions, including chronic elbow injuries and tennis elbow release. Additionally, in April 2021, MiMedx Group announced that the last patients in two late-stage Investigational New Drug (IND) trials had completed their previous clinical visits: Phase 3 studies of AmnioFix Injectable (micronized dehydrated Human Amnion Chorion Membrane (mdHACM)) as a potential treatment for Plantar Fasciitis and Achilles Tendonitis.
A lack of awareness about the condition and its advanced treatments among the population may negatively affect the market.
